_jamie-dimon-hints-at-impending-departure-jpmorgan-ceo39s-tenure-now-less-than-five-years.jpg "Jamie Dimon Hints at Impending Departure: JPMorgan CEO's Tenure Now Less Than Five Years from board Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 0:45
👁 View: 1.2M times
✓ Published: 22-May-2024
👁 View: 1.2M times
✓ Published: 22-May-2024
Description:
JPMorgan CEO Jamie Dimon signaled that his expected tenure is now less than five years, changing his standard response to retirement questions. Dimon, currently 68 years old, has led JPMorgan for nearly two decades and grown it into the largest bank by assets in the U.S. The timing of Dimon's succession has long been a key question for investors and analysts, given his pivotal role at the company. Dimon said the decision on when he steps down will ultimately be up to the board, but he still has the energy for the job. Dimon stated the company is moving people into positions in an apparent reference to succession planning. Even after retiring as CEO, Dimon is expected to remain as Chairman of JPMorgan after retiring as CEO
JPMorgan CEO Jamie Dimon signaled that his expected tenure is now less than five years, changing his standard response to retirement questions. Dimon, currently 68 years old, has led JPMorgan for nearly two decades and grown it into the largest bank by assets in the U.S. The timing of Dimon's succession has long been a key question for investors and analysts, given his pivotal role at the company. Dimon said the decision on when he steps down will ultimately be up to the board, but he still has the energy for the job. Dimon stated the company is moving people into positions in an apparent reference to succession planning. Even after retiring as CEO, Dimon is expected to remain as Chairman of JPMorgan after retiring as CEO
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_after-katy-perry-pitched-jelly-roll-as-her-39american-idol39-replacement-lionel-richie-pitched-two-big-names-i-love-even.webp "Ever since Katy Perry announced her impending exit from \")
⏲ 1:18 👁 83.2M
_board-and-batten-sidinginstallation-rrhq-is-looking-great.webp "RR Buildings")
_are-these-conference-finals-over-124-numbers-on-the-board.webp "Numbers On The Board")
_92.webp "A couple \")
_torontos-school-board-has-a-zero-tolerance-bullying-policy-unless-the-bullied-students-are-jewish.webp "Rebel News")
⏲ 17 minutes 41 seconds 👁 7K
_growing-number-of-americans-are-trying-weight-loss-drugs.webp "Growing , Number of Americans Are Trying , Weight-Loss Drugs.<br/>According to a recent poll, six percent of adults <br/>in the United States have already tried Ozempic <br/>or other brand name weight loss medications.<br/>According to a recent poll, six percent of adults <br/>in the United States have already tried Ozempic <br/>or other brand name weight loss medications.<br/>'Newsweek' reports that the Gallup poll numbers<br/>suggest that approximately 15.5 million Americans have <br/>used or are using an injectable diabetes medication. .<br/>'Newsweek' reports that the Gallup poll numbers<br/>suggest that approximately 15.5 million Americans have <br/>used or are using an injectable diabetes medication. .<br/>According to the poll, three percent <br/>of those users are specifically <br/>using the drug for weight loss.<br/>The poll found that people between the ages <br/>of 40 and 64 are the most likely to try Ozempic <br/>or competitors, like Wegovy or Saxenda. .<br/>In 2017, the U.S. Food and Drug <br/>Administration (FDA) approved Ozempic <br/>to treat cardiovascular disease and diabetes. .<br/>'Newsweek' reports that while Ozempic has <br/>not been approved for weight-loss purposes, <br/>its competitor Wegovy was approved in 2021. .<br/>'Newsweek' reports that while Ozempic has <br/>not been approved for weight-loss purposes, <br/>its competitor Wegovy was approved in 2021. .<br/>Both drugs rely upon the active ingredient <br/>semaglutide, however, Wegovy contains <br/>a higher amount than Ozempic.<br/>Both drugs rely upon the active ingredient <br/>semaglutide, however, Wegovy contains <br/>a higher amount than Ozempic.<br/>The popularity of the drug has resulted <br/>in various makers reporting shortages. .<br/>The drug companies didn't <br/>anticipate how popular <br/>these drugs would become, Sue Decotiis, Triple-board-certified medical <br/>weight-loss doctor in New York City, via 'Newsweek'.<br/>Since they are being used <br/>for many issues, like diabetes, <br/>heart failure, obesity, <br/>this exacerbates the <br/>shortages significantly, Sue Decotiis, Triple-board-certified medical <br/>weight-loss doctor in New York City, via 'Newsweek'")
_clarence-thomas-blasts-brown-v-board-of-education-in-redistricting-ruling.webp "Indisputable with Dr. Rashad Richey")
⏲ 8 minutes 59 seconds 👁 7.9K
_slay-the-spire-the-board-game-playthrough.webp "One Stop Co-op Shop")
_after-katy-perry-pitched-jelly-roll-as-her-39american-idol39-replacement-lionel-richie-pitched-two-big-names-i-love-even.jpg)
_board-and-batten-sidinginstallation-rrhq-is-looking-great.jpg)
_are-these-conference-finals-over-124-numbers-on-the-board.jpg)
_92.jpg)
_torontos-school-board-has-a-zero-tolerance-bullying-policy-unless-the-bullied-students-are-jewish.jpg)
_growing-number-of-americans-are-trying-weight-loss-drugs.jpg)
_clarence-thomas-blasts-brown-v-board-of-education-in-redistricting-ruling.jpg)
_slay-the-spire-the-board-game-playthrough.jpg)
![[+]](/images/menu.gif){kind=small}